Amanta Healthcare Ltd

Extending its winning streak to six sessions, Amanta Healthcare Ltd touched a fresh all-time high of Rs 192 on 09 Jul 2026, marking a 17.3% gain over this period and significantly outpacing the Sensex's modest gains.

Amanta Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 8 July 2026. This shift reflects a reassessment across key parameters including technical trends, valuation metrics, financial performance, and overall quality scores, signalling caution for investors despite recent strong price gains.

Amanta Healthcare Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating as of 8 July 2026. This change reflects evolving market perceptions amid strong price appreciation and sector-wide valuation trends, prompting a downgrade in its Mojo Grade from Hold to Sell. Investors should carefully analyse the implications of these valuation adjustments in the context of the company’s financial metrics and peer comparisons.

At Rs 188.79, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Amanta Healthcare Ltd locked at its upper circuit of 5% on 07 Jul 2026, with buyers queuing and no sellers willing to part with shares.

With a decisive surge to Rs 191 on 8 Jul 2026, Amanta Healthcare Ltd has reached a fresh 52-week and all-time high, propelled by a confluence of bullish technical indicators and sustained price momentum over the past week.

Extending its winning streak to five consecutive sessions, Amanta Healthcare Ltd surged 4.92% today to touch a fresh all-time high of Rs 191, significantly outpacing the Sensex which declined 0.76% in the same session.

At Rs 179.8, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Amanta Healthcare Ltd locked at its upper circuit of 5.0% on 7 Jul 2026, with buyers queuing and no sellers willing to part with shares.

With a decisive surge to Rs 181.95 on 7 Jul 2026, Amanta Healthcare Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum over recent sessions.

Amanta Healthcare Ltd, a player in the Pharmaceuticals & Biotechnology sector, achieved a significant milestone on 07 Jul 2026 as its stock price surged to an all-time high of Rs.181.95. This marks a notable moment in the company’s market journey, reflecting sustained gains and a bullish technical trend.

At Rs 171.24, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Amanta Healthcare Ltd locked at its upper circuit of 5.0% on 6 Jul 2026, with buyers queuing and no sellers willing to part with shares.

Surging to an all-time high of Rs 173.3 on 6 Jul 2026, Amanta Healthcare Ltd has demonstrated remarkable price momentum, outperforming its sector and marking a significant milestone in its trading history.

Extending its winning streak to three sessions, Amanta Healthcare Ltd surged 5% today to touch a fresh all-time high of Rs 173.30, significantly outpacing the Sensex which gained a modest 0.49%. This rally marks a 9.03% return over the past three days and a remarkable 62.33% gain over the last three months, underscoring the stock’s strong momentum across multiple timeframes.

Amanta Healthcare Ltd has seen its investment rating upgraded from Sell to Hold as of 3 July 2026, reflecting a notable improvement in its technical indicators and valuation metrics despite flat recent financial performance. The upgrade is driven by a combination of bullish technical trends, attractive valuation ratios, and increased institutional participation, balanced against ongoing challenges in long-term fundamentals and profitability.

Amanta Healthcare Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a combination of key technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, signalling renewed investor interest and potential upside in the pharmaceuticals and biotechnology sector.

Amanta Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 03 July 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 04 July 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

With every major moving average breached and key momentum indicators flashing positive signals, Amanta Healthcare Ltd surged to a new 52-week high of Rs 169 on 3 Jul 2026, marking a significant milestone in its price journey from Rs 93.1 a year ago.

Amanta Healthcare Ltd has reached a significant milestone by touching its all-time high price of ₹168.00 on 03 Jul 2026, marking a notable achievement in the Pharmaceuticals & Biotechnology sector. This surge reflects the company’s robust performance and sustained upward momentum in recent months.

At Rs 154.5, sellers were still queuing — but there were no buyers willing to take the other side. Amanta Healthcare Ltd locked at its lower circuit of 4.38% on 1 Jul 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.